Novasep is a CDMO specialized in viruses & viral vectors production for preclinical, clinical and commercial phases. Novasep offers global and integrated services from development to manufacturing, including Fill & Finish, also proposed as a stand-alone service.
With more than 15 years of experience, Novasep is recognized as a leader in manufacturing viral vectors (AAV, ADV, Lentivirus, HSV,’) for gene & cell therapy, immunotherapy and vaccination.

We recently unveiled a new commercial production facility, Senrise-IV, to fully complete the supply chain of your viral vector, from early development to commercial supply.